Claritas Pharmaceuticals (formerly Kalytera Therapeutics) to Focus on Development of R-107 as a Therapy for Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections – #stocks chatter

0
563

Claritas Pharmaceuticals (formerly Kalytera Therapeutics) to Focus on Development of R-107 as a Therapy for Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections

https://ca.finance.yahoo.com/news/claritas-pharmaceuticals-formerly-kalytera-therapeutics-123000138.html

This site uses Akismet to reduce spam. Learn how your comment data is processed.